Clinical trial
Genetics of QT Prolongation With Antiarrhythmics
NCT02439658 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetics of QT Prolongation With Antiarrhythmics
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2014
- Completion date
- April 30, 2023
- Enrollment
- 1,000 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
drug toxicity, long qt syndrome